{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:18:21Z","timestamp":1787498301528,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03467-8","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T08:02:27Z","timestamp":1693900947000},"page":"695-706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["No association effect of genetic polymorphism was observed between polycystic ovary syndrome and cardiovascular diseases risk: a mendelian randomization study"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1831-1475","authenticated-orcid":false,"given":"Xiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Huangfu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"issue":"5","key":"3467_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"H.F. Escobar-Morreale, Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 14(5), 270\u2013284 (2018)","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"3467_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/humrep\/dey343","volume":"34","author":"MA Brower","year":"2019","unstructured":"M.A. Brower et al. Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome. Hum Reprod 34(1), 127\u2013136 (2019)","journal-title":"Hum Reprod"},{"issue":"2","key":"3467_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/clinem\/dgab613","volume":"107","author":"C Riestenberg","year":"2022","unstructured":"C. Riestenberg et al. Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences. J Clin Endocrinol Metab 107(2), 575\u2013585 (2022)","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3467_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"JV Lazarus","year":"2022","unstructured":"J.V. Lazarus et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol 19(1), 60\u201378 (2022)","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"3467_CR5","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"C.W. Tsao et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation 145(8), e153\u2013e639 (2022)","journal-title":"Circulation"},{"issue":"8","key":"3467_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.steroids.2013.04.009","volume":"78","author":"A Dokras","year":"2013","unstructured":"A. Dokras, Cardiovascular disease risk in women with PCOS. Steroids. 78(8), 773\u2013776 (2013)","journal-title":"Steroids."},{"issue":"2","key":"3467_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/WHE.14.64","volume":"11","author":"RE Harvey","year":"2015","unstructured":"R.E. Harvey et al. Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease. Womens Health (Lond) 11(2), 239\u2013257 (2015)","journal-title":"Womens Health (Lond)"},{"issue":"12","key":"3467_CR8","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1177\/2047487320922927","volume":"28","author":"C Oliver-Williams","year":"2020","unstructured":"C. Oliver-Williams et al. Polycystic ovary syndrome as a novel risk factor for atrial fibrillation: results from a national Danish registry cohort study. Eur J Prev Cardiol 28(12), e20\u2013e22 (2020)","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"3467_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10840-014-9925-8","volume":"41","author":"R Zehir","year":"2014","unstructured":"R. Zehir et al. Assessment of atrial conduction time in patients with polycystic ovary syndrome. J Interv Card Electrophysiol 41(2), 137\u2013143 (2014)","journal-title":"J Interv Card Electrophysiol"},{"issue":"8","key":"3467_CR10","first-page":"772","volume":"13","author":"E Gazi","year":"2013","unstructured":"E. Gazi et al. Relationship of QT dispersion with sex hormones and insulin in young women with polycystic ovary syndrome: an observational study. Anadolu Kardiyol Derg 13(8), 772\u2013777 (2013)","journal-title":"Anadolu Kardiyol Derg"},{"issue":"16","key":"3467_CR11","doi-asserted-by":"publisher","first-page":"e025839","DOI":"10.1161\/JAHA.121.025839","volume":"11","author":"S Zahid","year":"2022","unstructured":"S. Zahid et al. Trends, predictors, and outcomes of cardiovascular complications associated with polycystic ovary syndrome during delivery hospitalizations: a national inpatient sample analysis (2002\u20132019). J Am Heart Assoc 11(16), e025839 (2022)","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"3467_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1530\/EJE-14-1108","volume":"172","author":"D Glintborg","year":"2015","unstructured":"D. Glintborg et al. Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome. Eur J Endocrinol 172(5), 627\u2013638 (2015)","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"3467_CR13","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/cen.12068","volume":"78","author":"H Mani","year":"2013","unstructured":"H. Mani et al. Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clin Endocrinol (Oxf) 78(6), 926\u2013934 (2013)","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"3467_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/heartjnl-2019-315555","volume":"106","author":"J Mehilli","year":"2020","unstructured":"J. Mehilli, P. Presbitero, Coronary artery disease and acute coronary syndrome in women. Heart 106(7), 487\u2013492 (2020)","journal-title":"Heart"},{"issue":"3","key":"3467_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1210\/jc.2014-3886","volume":"100","author":"R Hart","year":"2015","unstructured":"R. Hart, D.A. Doherty, The potential implications of a PCOS diagnosis on a woman\u2019s long-term health using data linkage. J Clin Endocrinol Metab 100(3), 911\u2013919 (2015)","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3467_CR16","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1210\/jc.2017-02421","volume":"103","author":"C Meun","year":"2018","unstructured":"C. Meun et al. High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam study. J Clin Endocrinol Metab 103(4), 1622\u20131630 (2018)","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3467_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.14744\/AnatolJCardiol.2017.24541","volume":"17","author":"R Perini","year":"2017","unstructured":"R. Perini, Heart rate variability in normal-weight patients with polycystic ovary syndrome. Anatol J Cardiol 17(5), 410\u2013411 (2017)","journal-title":"Anatol J Cardiol"},{"issue":"6","key":"3467_CR18","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.thromres.2015.10.022","volume":"136","author":"EM Okoroh","year":"2015","unstructured":"E.M. Okoroh et al. Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome. Thromb Res 136(6), 1165\u20131168 (2015)","journal-title":"Thromb Res"},{"issue":"9","key":"3467_CR19","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.18632\/oncotarget.23985","volume":"9","author":"DC Ding","year":"2018","unstructured":"D.C. Ding et al. Coronary artery disease risk in young women with polycystic ovary syndrome. Oncotarget 9(9), 8756\u20138764 (2018)","journal-title":"Oncotarget"},{"issue":"19","key":"3467_CR20","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"C.A. Emdin et al. Mendelian randomization. Jama 318(19), 1925\u20131926 (2017)","journal-title":"Jama"},{"issue":"6","key":"3467_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/jama.2016.21189","volume":"317","author":"G Davey Smith","year":"2017","unstructured":"G. Davey Smith et al. When will Mendelian randomization become relevant for clinical practice and public health? Jama 317(6), 589\u2013591 (2017)","journal-title":"Jama"},{"issue":"9","key":"3467_CR22","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jacc.2016.05.092","volume":"68","author":"SW Van Der Laan","year":"2016","unstructured":"S.W. Van Der Laan et al. Cystatin C and cardiovascular disease: a Mendelian randomization study. J Am Coll Cardiol 68(9), 934\u2013945 (2016)","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"3467_CR23","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","volume":"178","author":"BL Pierce","year":"2013","unstructured":"B.L. Pierce, S. Burgess, Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 178(7), 1177\u20131184 (2013)","journal-title":"Am J Epidemiol"},{"issue":"4","key":"3467_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/cen.14593","volume":"96","author":"P Simons","year":"2022","unstructured":"P. Simons et al. Causal relationship between polycystic ovary syndrome and coronary artery disease: a Mendelian randomisation study. Clin Endocrinol (Oxf) 96(4), 599\u2013604 (2022)","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"3467_CR25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2337\/db20-0800","volume":"70","author":"T Zhu","year":"2021","unstructured":"T. Zhu et al. Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke. Diabetes 70(2), 627\u2013637 (2021)","journal-title":"Diabetes"},{"issue":"12","key":"3467_CR26","doi-asserted-by":"publisher","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","volume":"14","author":"F Day","year":"2018","unstructured":"F. Day et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet 14(12), e1007813 (2018)","journal-title":"PLoS Genet"},{"issue":"6","key":"3467_CR27","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/ije\/dyx028","volume":"45","author":"FP Hartwig","year":"2016","unstructured":"F.P. Hartwig et al. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int J Epidemiol 45(6), 1717\u20131726 (2016)","journal-title":"Int J Epidemiol"},{"issue":"9","key":"3467_CR28","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.2384","volume":"44","author":"Y Shi","year":"2012","unstructured":"Y. Shi et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet 44(9), 1020\u20131025 (2012)","journal-title":"Nat Genet"},{"issue":"1","key":"3467_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng.732","volume":"43","author":"ZJ Chen","year":"2011","unstructured":"Z.J. Chen et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 43(1), 55\u201359 (2011)","journal-title":"Nat Genet"},{"issue":"4","key":"3467_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"J. Bowden et al. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4), 304\u2013314 (2016)","journal-title":"Genet Epidemiol"},{"issue":"3","key":"3467_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"S. Burgess, S.G. Thompson, Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 40(3), 755\u2013764 (2011)","journal-title":"Int J Epidemiol"},{"issue":"8","key":"3467_CR32","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"D.A. Lawlor et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8), 1133\u20131163 (2008)","journal-title":"Stat Med"},{"issue":"2","key":"3467_CR33","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"J. Bowden et al. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2), 512\u2013525 (2015)","journal-title":"Int J Epidemiol"},{"issue":"6","key":"3467_CR34","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"F.P. Hartwig et al. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol 46(6), 1985\u20131998 (2017)","journal-title":"Int J Epidemiol"},{"issue":"5","key":"3467_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"M. Verbanck et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5), 693\u2013698 (2018)","journal-title":"Nat Genet"},{"issue":"21","key":"3467_CR36","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","volume":"53","author":"CJ Lavie","year":"2009","unstructured":"C.J. Lavie et al. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53(21), 1925\u20131932 (2009)","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"3467_CR37","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/oby.23175","volume":"29","author":"ED Bode","year":"2021","unstructured":"E.D. Bode et al. Cardiovascular disease risk factors by BMI and age in United States firefighters. Obesity (Silver Spring) 29(7), 1186\u20131194 (2021)","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"3467_CR38","doi-asserted-by":"publisher","first-page":"e0122985","DOI":"10.1371\/journal.pone.0122985","volume":"10","author":"BC Lam","year":"2015","unstructured":"B.C. Lam et al. Comparison of body mass index (BMI), body adiposity index (BAI), waist circumference (WC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) as predictors of cardiovascular disease risk factors in an adult population in Singapore. PLoS One 10(4), e0122985 (2015)","journal-title":"PLoS One"},{"issue":"7","key":"3467_CR39","first-page":"587","volume":"34","author":"P Kaminski","year":"2013","unstructured":"P. Kaminski et al. Cardiovascular risk and the use of oral contraceptives. Neuro Endocrinol Lett 34(7), 587\u2013589 (2013)","journal-title":"Neuro Endocrinol Lett"},{"issue":"3","key":"3467_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40618-014-0215-1","volume":"38","author":"D Macut","year":"2015","unstructured":"D. Macut et al. Cardiovascular risk factors and events in women with androgen excess. J Endocrinol Invest 38(3), 295\u2013301 (2015)","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"3467_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1515\/jomb-2017-0020","volume":"36","author":"IP Blagojevic","year":"2017","unstructured":"I.P. Blagojevic et al. Women with polycystic ovary syndrome and risk of cardiovascular disease. J Med Biochem 36(3), 259\u2013269 (2017)","journal-title":"J Med Biochem"},{"issue":"20","key":"3467_CR42","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","volume":"32","author":"JR Staley","year":"2016","unstructured":"J.R. Staley et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics. 32(20), 3207\u20133209 (2016)","journal-title":"Bioinformatics."},{"key":"3467_CR43","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"G. Hemani et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 7, e34408 (2018)","journal-title":"Elife."},{"issue":"6","key":"3467_CR44","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","volume":"26","author":"V Wekker","year":"2020","unstructured":"V. Wekker et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update 26(6), 942\u2013960 (2020)","journal-title":"Hum Reprod Update"},{"key":"3467_CR45","doi-asserted-by":"publisher","first-page":"552421","DOI":"10.3389\/fcvm.2020.552421","volume":"7","author":"J Zhang","year":"2020","unstructured":"J. Zhang et al. Risk of cardiovascular and cerebrovascular events in polycystic ovarian syndrome women: a meta-analysis of cohort studies. Front Cardiovasc Med 7, 552421 (2020)","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"3467_CR46","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","volume":"52","author":"S Wild","year":"2000","unstructured":"S. Wild et al. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 52(5), 595\u2013600 (2000)","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"3467_CR47","first-page":"74","volume":"70","author":"S Iftikhar","year":"2012","unstructured":"S. Iftikhar et al. Risk of cardiovascular events in patients with polycystic ovary syndrome. Neth J Med 70(2), 74\u201380 (2012)","journal-title":"Neth J Med"},{"issue":"4","key":"3467_CR48","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1210\/jc.2005-2430","volume":"91","author":"JC Lo","year":"2006","unstructured":"J.C. Lo et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 91(4), 1357\u20131363 (2006)","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3467_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/09513590.2019.1650337","volume":"36","author":"F Ramezani Tehrani","year":"2020","unstructured":"F. Ramezani Tehrani et al. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol 36(1), 12\u201323 (2020)","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"3467_CR50","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1089\/jwh.2018.7162","volume":"27","author":"E Carmina","year":"2018","unstructured":"E. Carmina, R.A. Lobo, Is there really increased cardiovascular morbidity in women with polycystic ovary syndrome? J Womens Health (Larchmt) 27(11), 1385\u20131388 (2018)","journal-title":"J Womens Health (Larchmt)"},{"issue":"6","key":"3467_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.fertnstert.2017.09.034","volume":"108","author":"R Azziz","year":"2017","unstructured":"R. Azziz, Does the risk of diabetes and heart disease in women with polycystic ovary syndrome lessen with age? Fertil Steril 108(6), 959\u2013960 (2017)","journal-title":"Fertil Steril"},{"issue":"2","key":"3467_CR52","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","volume":"26","author":"KS Ruth","year":"2020","unstructured":"K.S. Ruth et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med 26(2), 252\u2013258 (2020)","journal-title":"Nat Med"},{"issue":"5","key":"3467_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11883-016-0575-4","volume":"18","author":"T Mandviwala","year":"2016","unstructured":"T. Mandviwala et al. Obesity and cardiovascular disease: a risk factor or a risk marker? Curr Atheroscler Rep 18(5), 21 (2016)","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"3467_CR54","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/ana.25686","volume":"87","author":"S Marini","year":"2020","unstructured":"S. Marini et al. Mendelian randomization study of obesity and cerebrovascular disease. Ann Neurol 87(4), 516\u2013524 (2020)","journal-title":"Ann Neurol"},{"issue":"2","key":"3467_CR55","doi-asserted-by":"publisher","first-page":"e1003679","DOI":"10.1371\/journal.pmed.1003679","volume":"19","author":"SS Venkatesh","year":"2022","unstructured":"S.S. Venkatesh et al. Obesity and risk of female reproductive conditions: a Mendelian randomisation study. PLoS Med 19(2), e1003679 (2022)","journal-title":"PLoS Med"},{"issue":"3","key":"3467_CR56","doi-asserted-by":"publisher","first-page":"e899","DOI":"10.1210\/clinem\/dgab757","volume":"107","author":"T Zhu","year":"2022","unstructured":"T. Zhu, M.O. Goodarzi, Causes and consequences of polycystic ovary syndrome: insights from Mendelian randomization. J Clin Endocrinol Metab 107(3), e899\u2013e911 (2022)","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3467_CR57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"D. Lizneva et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106(1), 6\u201315 (2016)","journal-title":"Fertil Steril"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03467-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03467-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03467-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T02:21:20Z","timestamp":1698718880000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03467-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3467"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03467-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2847955\/v1","asserted-by":"object"}]},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"22 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}